LIBERANT Trademark

Trademark Overview

On Thursday, March 30, 2023, a trademark application was filed for LIBERANT with the United States Patent and Trademark Office. The USPTO has given the LIBERANT trademark a serial number of 97864796. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 6, 2025. This trademark is owned by Medtronic, Inc. The LIBERANT trademark is filed in the Medical Instrument Products category with the following description:

Medical aspirators used for the restoration of blood flow to vessels of the peripheral arterial and venous systems and for the treatment of pulmonary embolisms and other pulmonary disorders
liberant

General Information

Serial Number97864796
Word MarkLIBERANT
Filing DateThursday, March 30, 2023
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Goods and ServicesMedical aspirators used for the restoration of blood flow to vessels of the peripheral arterial and venous systems and for the treatment of pulmonary embolisms and other pulmonary disorders

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, April 23, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedtronic, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMINNEAPOLIS, MN 55432
Party NameMedtronic, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMINNEAPOLIS, MN 55432

Trademark Events

Event DateEvent Description
Monday, April 3, 2023NEW APPLICATION ENTERED
Sunday, April 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 4, 2023ASSIGNED TO EXAMINER
Wednesday, October 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 3, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 11, 2023ASSIGNED TO PETITION STAFF
Friday, December 15, 2023POST PUBLICATION AMENDMENT - ENTERED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2024SOU EXTENSION 1 FILED
Tuesday, June 25, 2024SOU EXTENSION 1 GRANTED
Monday, December 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2024SOU EXTENSION 2 FILED
Monday, December 9, 2024SOU EXTENSION 2 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2025SOU EXTENSION 3 FILED
Monday, June 30, 2025SOU EXTENSION 3 GRANTED
Monday, October 6, 2025SOU TEAS EXTENSION RECEIVED
Monday, October 6, 2025SOU EXTENSION 4 FILED
Monday, October 6, 2025SOU EXTENSION 4 GRANTED
Monday, October 6, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 1, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

liberant pulmonary treatment venous systems embolisms disorders other arterial peripheral used